The Midwest Head and Neck Cancer Consortium Multi-Institutional Parathyroid Registry

Primary Hyperparathyroidism Clinical Trial

Official title:

The Midwest Head and Neck Cancer Consortium Multi-Institutional Parathyroid Registry

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01409798
• Other study ID #: 0324-10-EP
• Status: Completed
• Start date: June 9, 2010
• Est. completion date: April 27, 2015

Study information

• Verified date: August 2023
• Source: University of Nebraska
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this registry is to create a database that collects clinical data to improve knowledge about primary hyperparathyroidism.

Description:

This will be a multi-institutional prospective study in which patients that have undergone parathyroidectomy with intra-operative PTH assessment. The success of minimally invasive parathyroidectomy without and with intra-operative PTH will be assessed for each patient. Success for exploration without intra-operative PTH will be defined as directed exploration with detection of an abnormal parathyroid in the location suggested by imaging. Success with intra-operative PTH will be defined as per standard protocols (50% or > decrease in intra-operative PTH following excision).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 175
• Est. completion date: April 27, 2015
• Est. primary completion date: December 1, 2014
• Accepts healthy volunteers: No
• Gender: All
• Age group: 19 Years and older

Eligibility

Inclusion Criteria:

• Adult individuals (male and female) who have a personal diagnosis/history of primary hyperparathyroidism.

• Age 19 or greater.

• Patients who are seen and treated surgically at UNMC's Department of Otolaryngology- Head Neck Surgery .

• Able to provide informed consent.

Exclusion Criteria:

-No history of primary hyperparathyroidism

Related Conditions & MeSH terms

• Head and Neck Neoplasms
• Hyperparathyroidism
• Hyperparathyroidism, Primary
• Primary Hyperparathyroidism

Locations

Country	Name	City	State
United States	University Of Missiouri	Columbia	Missouri
United States	University of Iowa	Iowa City	Iowa
United States	Kansas University Medical Center	Lawrence	Kansas
United States	University of Minnesota	Minneapolis	Minnesota
United States	University of Nebraska Medical Center	Omaha	Nebraska
United States	Sanford School of Medicine	Sioux Falls	South Dakota

Sponsors (1)

Lead Sponsor	Collaborator
University of Nebraska

Country where clinical trial is conducted

United States,